We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$1.48B
AUM Growth
+$32M
Cap. Flow
+$45.1M
Cap. Flow %
3.05%
Top 10 Hldgs %
12.82%
Holding
987
New
371
Increased
2
Reduced
19
Closed
197
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSRXW
776
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$15K ﹤0.01%
+12,500
New +$11.5K
VLATW
777
DELISTED
Valor Latitude Acquisition Corp. Warrant
VLATW
$15K ﹤0.01%
+16,666
New +$14.8K
PKBOW
778
DELISTED
Peak Bio, Inc. Warrant
PKBOW
$15K ﹤0.01%
20,000
BSLKW
779
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$14K ﹤0.01%
+16,666
New +$12.5K
TSIBW
780
DELISTED
Tishman Speyer Innovation Corp. II Warrant
TSIBW
$13K ﹤0.01%
+10,000
New +$10.1K
LDHAW
781
DELISTED
LDH Growth Corp I Warrant
LDHAW
$12K ﹤0.01%
+10,000
New +$11K
SOC.WS
782
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$11K ﹤0.01%
+10,025
New +$7.4K
MVLAW
783
DELISTED
Movella Holdings Inc. Warrant
MVLAW
$10K ﹤0.01%
+10,000
New +$8.73K
PAQCW
784
DELISTED
Provident Acquisition Corp. Warrant
PAQCW
$9K ﹤0.01%
11,753
CREXW
785
DELISTED
Creative Realities, Inc. Warrant
CREXW
$6K ﹤0.01%
14,600
ASLE icon
786
AerSale
ASLE
$261M
-161,277
Closed -$1.98M
ATOS icon
787
Atossa Therapeutics
ATOS
$24.3M
-28,820
Closed -$912K
BEAM icon
788
Beam Therapeutics
BEAM
$2.39B
-268,820
Closed -$21.5M
CASI
789
DELISTED
CASI Pharmaceuticals
CASI
-30,000
Closed -$720K
CMMB
790
Chemomab Therapeutics
CMMB
$19.2M
-23,438
Closed -$2.69M
GPGI
791
GPGI Inc
GPGI
$3.53B
-17,683
Closed -$146K
BGMS
792
Bio Green Med Solution Inc
BGMS
$6.42M
-17
Closed -$423K
DGII icon
793
Digi International
DGII
$2.62B
-45,769
Closed -$869K
EYPT icon
794
EyePoint Inc
EYPT
$307M
-202,500
Closed -$2.06M
FTEK icon
795
Fuel Tech
FTEK
$54.6M
-1,162,228
Closed -$3.65M
HLLY icon
796
Holley
HLLY
$324M
-200,000
Closed -$2M
HLMN icon
797
Hillman Solutions
HLMN
$1.42B
-75,000
Closed -$751K
ICAD
798
DELISTED
iCAD Inc
ICAD
-83,500
Closed -$1.77M
IFRX icon
799
InflaRx
IFRX
$296M
-836,881
Closed -$3.26M
IMNN icon
800
Imunon
IMNN
$8.02M
-1,727
Closed -$466K

Similar funds

CVI Holdings's Q2 2021 Portfolio in Review

As of Q2 2021, CVI Holdings held 987 positions worth $1.48B, up 2.2% from $1.45B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

CVI Holdings deployed $45.1M of net new capital in Q2 2021, opening 371 new positions and adding to 2 existing holdings. Its largest new stake was FTAC Hera Acquisition Corp. Class A Ordinary Shares: 2,000,000 shares worth $19.5M.

By sector, the portfolio is most concentrated in Financials at 51% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Nuvation Bio, an estimated $11M trimmed.

  • CVI Holdings's largest Q2 2021 buy was FTAC Hera Acquisition Corp. Class A Ordinary Shares: 2,000,000 shares worth $19.5M.
  • CVI Holdings added most to Blue Owl Capital in Q2 2021, an estimated $19.1M increase.
  • CVI Holdings's biggest Q2 2021 reduction was Nuvation Bio, cutting an estimated $11M.
  • CVI Holdings fully exited Piedmont Lithium Limited American Depositary Receipts in Q2 2021, selling an estimated $38.6M.
  • CVI Holdings's ten largest holdings make up 13% of its $1.48B portfolio in Q2 2021.
  • CVI Holdings opened 371 new positions and closed 197 in Q2 2021.
  • CVI Holdings's portfolio value rose 2.2% quarter-over-quarter to $1.48B.

Based on CVI Holdings's 13F filing for Q2 2021, filed 11 Aug 2021.